Bill Gates, Alzheimer’s Association provide $740K grant to RTP startup Date Published: August 28, 2020 RESEARCH TRIANGLE PARK – T3D Therapeutics, a life science startup seeking to develop a treatment for Alzheimer’s disease, has another…
RTP-based APIE Therapeutics, RTI team up to develop drug for rare lung disease Date Published: August 26, 2020 RESEARCH TRIANGLE PARK — RTI International is teaming up with a local biopharma startup to develop a treatment for a…
California investor spends $590 million to expand footprint in Research Triangle Park Date Published: August 25, 2020 A huge portion of a campus in Research Triangle Park has been sold in a deal that tops $590 million.…
Durham life science startup IMMvention shines in LaunchBio Big Pitch competition Date Published: August 21, 2020 RESEARCH TRIANGLE PARK – IMMvention Therapeutix almost hit The Big Pitch out of the park. Almost. The 4-year-old Durham company,…
Triangle’s G1 Therapeutics reaches key milestone in fight against cancer Date Published: August 19, 2020 RESEARCH TRIANGLE PARK – G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory…
Frontier Warren begins first NC IDEA training Date Published: August 17, 2020 A little over a month since opening its second building on South Main Street in Warrenton, Frontier Warren began its…
Multinational firm UPL is looking for R&D partners, adding jobs at new RTP hub Date Published: August 14, 2020 RESEARCH TRIANGLE PARK – UPL, a multinational agriculture company based in India, has opened a global research-and-development hub in Research…
Backstory: A look at RTP’s growing gene therapy hub as startup brings 200+ $102,000 jobs to Durham Date Published: August 12, 2020 RESEARCH TRIANGLE PARK – A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell…
Beam Therapeutics to build $83M manufacturing facility in RTP, create hundreds of jobs Date Published: August 12, 2020 RALEIGH — Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83…